SEC FORM 4
—
Barinthus Biotherapeutics plc. (BRNS)
Acquisition (code A) of 361,530 shares; price not stated (see filing).
Reporting Person Hooftman Leon · Officer Title Chief Medical Officer · Transaction Code A
Traded Sep 9, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001104659-26-106338 · filed 2026-09-09 · View filing →